Amanote Research
Register
Sign In
NSCLC: Atezolizumab Mit Überlebensvorteil Unabhängig Vom PD-L1-Status
Pneumologie
- Germany
doi 10.1055/s-0043-105724
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Pulmonary
Respiratory Medicine
Date
June 1, 2017
Authors
Unknown
Publisher
Georg Thieme Verlag KG
